Brief: BRAIN Biotech FY Revenue Up At EUR 38.4 Mln

BRAIN Biotech AG

17/01/2022 06:37

Jan 17 (Reuters) - BRAIN BIOTECH AG  BNNn.DE :
    * BRAIN GROUP REVENUES INCREASED IN FINANCIAL YEAR 2020/21
    * FY EBITDA LOSS AND NET LOSS SIGNIFICANTLY REDUCED
    * REVENUE OF BRAIN GROUP GREW TO EUR 38.4 MILLION IN 2020/21
FINANCIAL YEAR
    * FY 2021 BRAIN'S REPORTED EBITDA SIGNIFICANTLY IMPROVED
FROM EUR
-3.9 MILLION TO EUR -2.5 MILLION
    * COMPARED WITH PREVIOUS YEAR (EUR 38.2 MILLION), THIS
REPRESENTS
AN INCREASE OF 0.4 %. ON AN ORGANIC BASIS - IN OTHER WORDS,
EXCLUDING ACQUISITION OF BIOSUN BIOCHEMICALS INC., TAMPA, USA -
REVENUE DECREASED BY 5.2 %
    * IN 2020/21 FINANCIAL YEAR, A TOTAL OF TEN IMPORTANT
MILESTONES
WERE ACHIEVED AS PLANNED
    * AT EUR 40.7 MILLION, FY TOTAL OPERATING PERFORMANCE WAS
3.8 % UP
ON PREVIOUS YEAR (EUR 39.2 MILLION)

Source text for Eikon:  ID:nEQHz5X2a 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))